seri
dhpm
synthes
character
ir
h
nmr
c
nmr
hrm
spectra
compound
evalu
vitro
antivir
activ
broad
rang
dna
rna
virus
along
assess
potenti
cytotox
divers
mammalian
cell
line
compound
possess
long
lipophil
side
chain
found
potent
select
inhibitor
punta
toro
viru
member
bunyavirida
rift
valley
fever
viru
anoth
bunyaviru
activ
neglig
dhpm
aryl
moieti
bear
halogen
substitut
found
cytotox
cell
elsevi
ltd
right
reserv
emerg
reemerg
virus
capabl
rapidli
overcom
natur
geograph
boundari
spread
among
human
popul
viral
outbreak
due
zoonot
virus
previous
unknown
increas
risk
vectorborn
outbreak
bunyavirida
present
particular
global
threat
public
health
member
viru
famili
caus
hantaviru
cardiopulmonari
syndrom
america
schmallenberg
virusinduc
congenit
malform
rumin
emerg
europ
sever
fever
thrombocytopenia
syndrom
sft
emerg
infecti
diseas
caus
sft
viru
addit
wellknown
bunyavirus
like
rift
valley
fever
viru
rvfv
crimeancongo
haemorrhag
fever
viru
continu
emerg
new
geograph
locat
rvfv
transmit
wide
varieti
mosquito
geograph
distribut
expand
potenti
reach
europ
near
futur
viru
caus
devast
epidem
africa
arabia
kill
hundr
human
thousand
wild
livestock
anim
transmiss
bunyavirus
cell
entri
pathway
cell
receptor
remain
poorli
character
partli
due
fact
experi
wildtyp
rvfv
limit
enhanc
biosafeti
facil
number
lack
vaccin
antivir
medic
make
potenti
spread
bunyavirus
global
concern
recent
effort
repurpos
fdaapprov
drug
rvfv
treatment
anticanc
drug
sorafenib
found
effect
inhibitor
rvfv
replic
anoth
agent
abl
suppress
rvfv
replic
cell
cultur
polyanion
drug
suramin
biginelli
condens
wellknown
reaction
year
old
except
simpl
straightforward
acidcatalyz
onepot
cyclocondens
reaction
ethylacetoacet
aldehyd
urea
afford
dhpm
biginelli
compound
number
variat
give
higher
yield
expand
scope
versu
tradit
threecompon
biginelli
condens
result
mani
simpl
deriv
emerg
promis
therapeut
agent
monastrol
discov
prototyp
anticanc
drug
inhibit
mitot
protein
methyl
deriv
develop
antihepat
b
viru
hbv
agent
target
viral
capsid
assembl
crambescin
contain
dhpm
core
isol
spong
cramb
cramb
batzella
sp
demonstr
possess
antivir
cytotox
properti
batzelladin
b
dhpm
core
identifi
inhibitor
hiv
bind
receptor
fig
howev
major
studi
exclud
limit
aliphat
aldehyd
within
scope
due
troublesom
behavior
unaccept
yield
multicompon
reaction
still
desir
optim
reaction
employ
aliphat
aldehyd
present
work
aim
synthes
one
use
variou
aromat
aliphat
aldehyd
evalu
antivir
activ
broad
rang
dna
rna
virus
along
cytotox
assess
divers
mammalian
cell
line
synthesi
desir
compound
depict
scheme
bear
aryl
styryl
moieti
prepar
excel
yield
via
neat
condit
without
solvent
catalyst
wherea
reaction
scheme
employ
salicyl
aldehyd
neat
condit
tricycl
compound
ie
oxygen
bridg
pyrimidinon
obtain
good
yield
howev
util
aliphat
aldehyd
neat
condit
lead
neglig
yield
desir
compound
data
shown
unsubstitut
dhpm
deriv
aliphat
group
achiev
use
excess
urea
reflux
condit
employ
acet
acid
mild
acid
catalyst
ethanol
yield
rang
synthes
compound
character
ir
h
nmr
c
nmr
hrm
supplementari
data
antivir
activ
cytotox
determin
previous
describ
method
compound
plu
virus
ad
plate
contain
subconflu
cell
cultur
cytotox
compound
assess
microscop
examin
yield
minim
cytotox
concentr
mcc
altern
colorimetr
formazanbas
mt
assay
use
determin
cytotox
concentr
cc
valu
antivir
activ
cytotox
synthes
compound
determin
cpe
reduct
assay
broad
divers
panel
dna
rna
virus
use
relev
mammalian
cell
line
result
evalu
vero
cell
cultur
present
tabl
compound
found
select
potent
inhibitor
punta
toro
viru
ptv
member
famili
bunyavirida
genu
phleboviru
approxim
time
potent
viral
entri
inhibitor
dextran
sulphat
broadspectrum
act
mycophenol
acid
inhibitor
cellular
imp
dehydrogenas
compar
broad
antivir
agent
ribavirin
prove
time
potent
superior
activ
ec
valu
lm
select
index
ratio
cytotox
concentr
effect
antivir
concentr
antiptv
effect
dosedepend
achiev
protect
virusinduc
cpe
lm
compound
sinc
ptv
relat
clinic
relev
phleboviru
rvfv
next
evalu
effect
rvfv
viru
classifi
viru
therefor
use
lowpathogen
strain
although
reduct
rvfvinduc
cpe
seen
compound
concentr
lm
unabl
achiev
inhibit
high
concentr
data
shown
also
evalu
ptv
hela
cell
found
inact
contrast
mark
effect
seen
vero
cell
see
henc
antivir
effect
appear
celldepend
alik
describ
antiebola
viru
activ
brincidofovir
antivir
drug
lipophil
moieti
structur
similar
among
dhpm
seri
synthes
distinguish
structur
featur
long
lipophil
chain
posit
polar
dihydropyrimidinon
scaffold
lead
us
assum
observ
antiptv
activ
mainli
depend
undecyl
moieti
confer
amphiphil
properti
amphiphil
molecul
larg
polar
head
group
invertedconeshap
known
target
viral
membran
display
broadspectrum
antivir
activ
howev
except
punta
toro
viru
antivir
activ
virus
test
molecul
display
modest
cytotox
tabl
summari
effici
reaction
condit
develop
util
aliphat
aldehyd
biginelli
condens
ethyl
follow
cell
line
use
vero
african
green
monkey
kidney
cell
hela
cervix
carcinoma
cell
mdck
madindarbi
canin
kidney
cell
hel
human
embryon
lung
fibroblast
cell
crfk
crandellre
felin
kidney
cell
human
tlymphoblast
cell
mcc
minim
cytotox
concentr
compound
concentr
produc
minim
alter
cell
morpholog
detect
microscop
inspect
b
cc
cytotox
concentr
determin
colorimetr
formazanbas
mt
cell
viabil
test
display
select
potent
antivir
activ
punta
toro
viru
base
first
result
evalu
bunyavirus
crimeancongo
haemorrhag
fever
viru
warrant
also
mechanist
studi
underway
understand
biochem
basi
antivir
effect
punta
toro
viru
